Replies to post #402055 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I know we all stress the TLD, Journal publication, etc. but one document is really what matters in terms of when DCVax-L can be approved, that's the BLA. I believe we may have sections of the BLD under review in a rolling BLA with one or more of the regulators, but whether that's true or not, completing and submitting the BLA is the key to approval, the rest is icing on the cake.

People here have "believed" a rolling BLA has been in submission for over 5 years.

Reality is that it is 100% quackery. Always has been, always will be.

When dev stage bios have news like they are actually submitting a BLA, they ALL shout it out. When a company stays dark, they have no such good news.